SLRN

ACELYRIN
SLRN

Overview Fund Activity
Delisted

SLRN was delisted on the 21st of May, 2025.

Back to rankings

122 hedge funds and large institutions have $430M invested in ACELYRIN in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 11 closing their positions.

Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
1.77%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
44
Reduced
35
Closed
11
Calls
$154K
Puts
$272K
Net Calls
-$118K
Net Calls Change
-$107K

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$51.4M
2
SC
2
Stempoint Capital
New York
$6.5M
3
Millennium Management
3
Millennium Management
New York
$27.1M
4
BlackRock
4
BlackRock
New York
$29.5M
5
Morgan Stanley
5
Morgan Stanley
New York
$8.81M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$580K
2
AG
2
Artal Group
Luxembourg
$0
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$4.19M
4
WP
4
Woodline Partners
California
$1.76M
5
Citadel Advisors
5
Citadel Advisors
Florida
$32.2M
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$51.4M 10,431,846 +7,079,539 +211%
ACMC
2
AyurMaya Capital Management Company
New Hampshire
$46M 9,334,735 – –
Citadel Advisors
3
Citadel Advisors
Florida
$32.2M 6,523,306 -887,258 -12%
BlackRock
4
BlackRock
New York
$29.5M 5,982,374 +713,000 +14%
Millennium Management
5
Millennium Management
New York
$27.1M 5,487,172 +845,116 +18%
Vanguard Group
6
Vanguard Group
Pennsylvania
$20.1M 4,066,989 -676,412 -14%
O
7
OrbiMed
New York
$19.7M 4,001,711 – –
VP
8
venBio Partners
California
$19M 3,852,470 – –
TCM
9
Tybourne Capital Management
Hong Kong
$14.3M 2,906,629 – –
GA
10
General Atlantic
New York
$14.2M 2,889,668 – –
BOCH
11
Blue Owl Capital Holdings
New York
$13.8M 2,793,946 -132,082 -5%
SB
12
Samsara BioCapital
California
$12.4M 2,523,022 – –
OM
13
Opaleye Management
Massachusetts
$9.34M 1,893,660 +313,660 +20%
PAI
14
Palo Alto Investors
California
$8.84M 1,792,895 +77,715 +5%
Morgan Stanley
15
Morgan Stanley
New York
$8.81M 1,786,453 +533,637 +43%
SL
16
Siren LLC
Connecticut
$8.53M 1,729,665 +1,729,665 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$8.14M 1,651,614 +388,631 +31%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$6.54M 1,326,391 -153,465 -10%
SC
19
Stempoint Capital
New York
$6.5M 1,317,854 +1,317,854 New
State Street
20
State Street
Massachusetts
$6.28M 1,273,096 +116,094 +10%
RI
21
RTW Investments
New York
$4.82M 978,310 – –
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$4.19M 850,661 -1,747,642 -67%
KCM
23
Kynam Capital Management
New Jersey
$4.18M 847,366 +16,056 +2%
IC
24
Ikarian Capital
Texas
$3.34M 677,074 -798,000 -54%
Charles Schwab
25
Charles Schwab
California
$3.01M 609,678 +273,604 +81%
1
2 3 4 5